# Hubert Piessevaux

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hubert-piessevaux/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,307 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 40 |
| i10-index | 76 |
| Last Known Institution | Cliniques Universitaires Saint-Luc |
| OpenAlex ID | https://openalex.org/A5079885399 |
| ORCID iD | 0000-0003-1193-0601 |
| Works | 262 |

## Researcher papers

- [Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis](https://scholariq.org/papers/effects-of-kras-braf-nras-and-pik3ca-mutations-on-the-efficacy-of-cetuximab-plus/)
- [Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline](https://scholariq.org/papers/endoscopic-submucosal-dissection-european-society-of-gastrointestinal-endoscopy/)
- [Role of impaired gastric accommodation to a meal in functional dyspepsia](https://scholariq.org/papers/role-of-impaired-gastric-accommodation-to-a-meal-in-functional-dyspepsia/)
- [KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab](https://scholariq.org/papers/kras-wild-type-state-predicts-survival-and-is-associated-to-early-radiological/)
- [Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab](https://scholariq.org/papers/association-of-kras-p-g13d-mutation-with-outcome-in-patients-with-chemotherapy/)
- [Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia](https://scholariq.org/papers/symptoms-associated-with-hypersensitivity-to-gastric-distention-in-functional/)
- [Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab](https://scholariq.org/papers/amphiregulin-and-epiregulin-mrna-expression-in-primary-tumors-predicts-outcome/)
- [Use of Early Tumor Shrinkage to Predict Long-Term Outcome in Metastatic Colorectal Cancer Treated With Cetuximab](https://scholariq.org/papers/use-of-early-tumor-shrinkage-to-predict-long-term-outcome-in-metastatic/)
- [Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study](https://scholariq.org/papers/magnesium-wasting-associated-with-epidermal-growth-factor-receptor-targeting/)
- [Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients](https://scholariq.org/papers/stepwise-radical-endoscopic-resection-for-eradication-of-barrett-s-oesophagus/)
- [Irritable bowel syndrome-like symptoms before and after bariatric surgery and association with short-chain fermentable carbohydrates consumption: an observational prospective study](https://scholariq.org/papers/irritable-bowel-syndrome-like-symptoms-before-and-after-bariatric-surgery-and/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)

## Researcher university

- [Cliniques Universitaires Saint-Luc](https://scholariq.org/institutions/cliniques-universitaires-saint-luc/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.